BRAIN, FOCUS & MOOD RESEARCH
A synthetic ACTH(4-10) analogue developed in Russia, studied as a nootropic and neuroprotective peptide.
Semax is a synthetic analogue of ACTH(4-10) developed in Russia, where it has a long clinical-use history for cognitive and neuroprotective applications. It is studied for focus, memory, and recovery from neurological stress, with a well-described BDNF-driven mechanism.
Included because it has decades of documented Russian clinical use—material foreign evidence—alongside a described BDNF-based mechanism and a consistent research-use history. Its foreign clinical foundation distinguishes it from newer, unstudied analogues.
Up-regulates BDNF and TrkB receptors, associated with neurogenesis.
Increases dopamine and serotonin activity and boosts enkephalins and neuroplasticity.
Crosses the blood-brain barrier rapidly.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
Semax is used clinically in Russia and some other countries but is not FDA-approved. Sold and offered strictly for laboratory and research use.
